Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Centre for Process Innovation
Centre for Process Innovation
Activities:
Research & Development
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Syngene opens novel biologics manufacturing facility
New facility includes 20KL of single use drug substance capacity, coupled with drug product filling capacity of up to one million vials per day
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
AstraZeneca to acquire Amolyt Pharma for up to $1.05 billion
The acquisition will facilitate the development of novel therapeutics for rare endocrine and related diseases
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Pfizer partners with Medicines Manufacturing Innovation Centre
The company will be participating in the centre’s first ‘grand challenge,’ aiming to develop a continuous direct compression platform for oral solid dosage medicines
Research & Development
MicrofluidX makes key collaboration for microfluidics platform
CPI, MicrofluidX and the Cell and Gene Therapy Catapult have collaborated to develop bioprocessing technology for the rapid scale-up of cell and gene therapies
CPI CEO passes the torch
Nigel Perry has stepped down as CEO and will be succeeded by COO, Frank Millar
Research & Development
CPI and Oxford University join forces to lower NADH production cost
A constant feed of the expensive cofactor NADH is a requirement in many biocatalytic reactions and this has hindered industrial adoption of the technology
Ingredients
Rapid formulation stability screening platform tests real-world use
Following two years of research by CPI at Imperial College London and the University of Durham, the project is now translating the academic work into real-world applications
Ingredients
Research partnership removes bottleneck from AAV development
CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Manufacturing
Innovation centre works with pharma giants on continuous manufacturing
CPI and Strathclyde University’s strategic partnership with GSK and AstraZeneca has begun work on a continuous direct compression platform for oral solid dosage medicines
Subscribe now